Yan Zhang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis

Epithelial Mesenchymal Transition

Top Venues

Science translational medicine

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Mingyue Liu, Xu Wang, Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang, Chunxia Ai, Martin Devenport, Juanjuan Su, Musleh M Muthana, Lishan Su, Yang Liu, Peng Zhang
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy. Science translational medicine 15 (685) (2023)
Mingyue Liu, Xu Wang, Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang, Chunxia Ai, Martin Devenport, Juanjuan Su, Musleh M Muthana, Lishan Su, Yang Liu, Peng Zhang
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy. Science translational medicine 15 (685) (2023)
Mingyue Liu, Xu Wang, Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang, Chunxia Ai, Martin Devenport, Juanjuan Su, Musleh M Muthana, Lishan Su, Yang Liu, Peng Zhang
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy. Science translational medicine 15 (685) (2023)
Zheng Wei, Yan Zhang, Jingjing Chen, Yu Hu, Pan Jia, Xuelei Wang, Qifang Zhao, Yicong Deng, Ni Li, Yi Zang, Jun Qin, Xiaoming Wang, Wei Lu
Pathogenic CARD11 mutations affect B cell development and differentiation through a noncanonical pathway. Science immunology 4 (41) (2020)